Ali Ashrafzadeh

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot et al. · The Lancet Rheumatology · 2020 · 286 citations

Advanced Lung Disease, Systemic Sclerosis, Pulmonary Fibrosis +3

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial

Paul P. Tak, Philip J. Mease, Mark C. Genovese et al. · Arthritis & Rheumatism · 2012 · 65 citations

Immunology, Pharmacotherapy, Inflammatory Arthritis +16

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial

William Stohl, Juan J. Gómez‐Reino, Ewa Olech et al. · Annals of the Rheumatic Diseases · 2012 · 55 citations · Full text

A High-Yield Two-Hour Protocol for Extraction of Human Hair Shaft Proteins

Sing Ying Wong, Ching Chin Lee, Ali Ashrafzadeh et al. · PLoS ONE · 2016 · 36 citations · Full text

Biological Mass Spectrometry, Molecular Biology, High-yield Two-hour Protocol +18

Unmasking Heavily O-Glycosylated Serum Proteins Using Perchloric Acid: Identification of Serum Proteoglycan 4 and Protease C1 Inhibitor as Molecular Indicators for Screening of Breast Cancer

Cheng-Siang Lee, Nur Aishah Mohd Taib, Ali Ashrafzadeh et al. · PLoS ONE · 2016 · 33 citations · Full text